Elucidating the exact pharmacological mechanism of action (MOA) of naturally occurring compounds is usually tough. While Tarselli et al. (60) developed the primary de novo artificial pathway to conolidine and showcased this naturally transpiring compound efficiently suppresses responses to each chemically induced and inflammation-derived pain, the